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Abstract 
Periodontal disease is an inflammatory condition that destroys the tooth-supporting 
tissues. The inflammation is initiated by oral bacteria in the form of multi-species 
biofilms, and is dominated by cytokines of the IL-1 family. IL-1 activation and 
processing is regulated by Caspase-1, within intracellular protein complexes, known 
as “inflammasomes”. The present study employed culture supernatants of in vitro 
supragingival and subgingival biofilms, to challenge human GF cultures for 6 h. The 
gene expression of inflammasome complex components was investigated by TaqMan 
qPCR. NLRP1 expression was not affected, whereas NLRP2 was not expressed. 
Supragingival biofilm challenge increased the expression of Caspase-1, the adaptor 
ASC, AIM2, as well as IL-1β and IL-18, but did not affect NLRP3 expression. 
Subgingival biofilm challenge enhanced Caspase-1, ASC, AIM2, IL-1β and IL-18 
gene expression at lower concentrations, followed by their down-regulation at higher 
concentrations, which was also evident for NLRP3 expression. Hence, supragingival 
and subgingival biofilms differentially regulate the gene expressions of NLRP3 and 
AIM2 inflammasomes and their down-stream IL-1 targets. Increased inflammasome 
transcription in response to supragingival biofilms is commensurate with early 
inflammatory events in periodontal disease, whereas decreased transcription in 
response to subgingival biofilms corroborates the dampening of host immune 
responses, in favour of pathogen survival and persistence. 
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1. Introduction 
Periodontal diseases are the most common chronic inflammatory diseases in man. 
They are characterised by the inflammatory destruction of the tooth supporting 
(periodontal) tissues, eventually leading to tooth loss if left untreated. The etiological 
factor of this cluster of diseases is oral bacteria colonizing the tooth surfaces as 
polymicrobial biofilm communities [1]. Biofilms interact with the surrounding tissues 
periodontal tissues, triggering immune responses that result in tissue-destructive 
inflammation. Depending on the localization of the biofilm in relation to the gingival 
margin, this can be either “supragingival” (above) or “subgingival” (below) [2]. 
Bacterial products released by the biofilms can cause an inflammatory response by the 
periodontal tissues, aiming to eliminate the bacterial challenge [3]. However, rather 
than being protective, an excessive inflammatory response induces periodontal tissue 
damage [4]. Gingivitis is a form of periodontal disease in which the inflammatory 
response is restricted to the superficial gingival tissue, and is typically associated with 
the presence of a supragingival biofilm. It may progress to periodontitis, which 
involves further the inflammatory destruction of the tooth-supporting alveolar bone 
and interconnecting periodontal ligament, attributed mainly to highly virulent 
subgingival biofilms [1, 2, 5, 6]. Cytokines of the Interleukin(IL)-1 family, including 
IL-1β and IL-18, are central to the inflammatory host response in periodontal diseases 
[7, 8]. High IL-1β levels are detected in the gingival crevicular fluid [9] or gingival 
tissues [10], of patients with periodontal disease. 
Inflammasomes are oligomeric molecular platforms that trigger the maturation 
of IL-1 cytokines in response to infection or stress signals at the cellular level, in 
order to engage them into innate immune defences [11]. The most well characterised 
inflammasomes are of the nucleotide-binding oligomerization domain-like receptor 
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(NLR). They are essentially intracellular pattern recognition receptors (PRRs) that 
detect pathogen-associated or danger-associated molecular patterns (PAMPs and 
DAMPs). The recognition of PAMPs or DAMPs by NLRs leads to the recruitment 
and activation of cysteine proteinase Caspase-1. In turn, Caspase-1 proteolytically 
activates the intracellularly stored pro-IL-1β into its mature secreted form, so that it 
can exert its pro-inflammatory properties. The NLRP3 inflammasome in particular, 
consists of three components, namely the NLRP3 scaffold, Caspase-1 and apoptotic 
speck protein containing a C-terminal caspase recruitment domain (ASC), the adaptor 
molecule that mediates the interaction of the former two. This inflammasome is 
activated in response to cell stress signals [12], bacteria and viruses, or their virulence 
factors [13-16], and is likely to play a key role in inflammatory periodontal disease 
[10]. Less information is currently available on NLRP2, but it is considered to be an 
inhibitor of the NLRP3-ASC interaction [17, 18]. The NLRP1 inflammasome is 
structurally different to NLRP3, as it does not require the mediation of ASC for the 
activation of Caspase-1 [19], and it can also activate Caspase-5 [20]. So far, this 
inflammasome is shown to be activated by the anthrax lethal toxin, causing cell death 
[21]. Absent In Melanoma (AIM)2 is a recently discovered non-NLR inflammasome 
that senses cytosolic double-stranded DNA, consequently inducing Caspase-1-
dependent IL-1β maturation [22]. It is activated by a broad spectrum of DNA sources, 
such as bacteria, viruses, or even the host. A shared feature with the NLRP3 
inflammasome is that the AIM2 platform also consists of ASC and Caspase-1 [23]. 
The gingival connective tissue has an important role in the protection and 
homeostasis of the periodontium. The main cell population of this tissue are the 
gingival (GF), synthesizing its collagenous matrix, but also responding to bacterial 
challenge by producing mediators of inflammation [24]. Non-immune cells, such as 
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GF, can recognize danger signals and initiate inflammatory responses in anatomical 
compartments less accessible to myeloid cells, thus fulfilling tasks usually performed 
by residential macrophages [25]. Although GF are less potent than macrophages in 
inflammatory cytokine production, their inflammasome expression could still regulate 
local host responses in the periodontium. To this extent, synovial fibroblasts are 
shown to express NLRP3 in models related to rheumatoid arthritis [26, 27].  
Neither the expression of inflammasomes, nor their potential responses to 
polymicrobial oral biofilms have been investigated in GF. The present in vitro study 
aims to compare the capacity of a supragingival and a subgingival biofilm model to 
regulate the gene expression of various inflammasome components in human GF 
cultures. 
 
2. Materials and Methods 
2.1 In vitro biofilm model 
The 6-species suprgagingival Zürich biofilm model [28] used in this study consisted 
of Veillonella dispar ATCC 17748 (OMZ 493), Fusobacterium nucleatum KP-F8 
(OMZ 598), Streptococcus oralis SK248 (OMZ 607), Actinomyces naeslundii (OMZ 
745), Streptococcus mutans UAB159 (OMZ 918) and Candida albicans (OMZ 110).  
The 10-species subgingival Zürich biofilm model [29] used in this study consisted of 
Campylobacter rectus (OMZ 697), F. nucleatum subsp. vincentii KP-F2 (OMZ 596), 
Porphyromonas gingivalis ATCC 33277T (OMZ 925), Prevotella intermedia ATCC 
25611T (OMZ 278), Tannerella forsythia OMZ 1047, Treponema denticola ATCC 
35405T (OMZ 661), V. dispar ATCC 17748T (OMZ 493), A. naeslundii OMZ 745, S. 
intermedius ATCC 27335 (OMZ 512), and S. oralis SK 248 (OMZ 607). Briefly, the 
supragingival or subgingival biofilms were grown in 24-well cell culture plates on 
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sintered hydroxyapatite discs, resembling natural tooth surfaces, and were pre-
conditioned for pellicle formation with human mixed saliva for 4 h. To initiate 
biofilm formation, hydroxyapatite discs were covered for 16.5 h with 1.6 ml of 
growth medium consisting of 60% saliva, 10% human serum (pooled from three 
donors), 30% FUM culture medium [30] and 200 µl of a bacterial cell suspension 
containing equal volumes and density from each strain. After 16.5 h of anaerobic 
incubation at 37°C, the inoculum suspension was removed from the discs by 'dip-
washing' using forceps, transferred into wells with fresh medium (60% saliva, 10% 
human serum, 30% FUM), and incubated for further 48 h in anaerobic atmosphere. 
During this time-period, the discs were dip-washed 3x and given fresh medium once 
daily. After a total 64.5 h of incubation, the biofilm supernatants were collected, 
filtered and stored at -80°C. The bacterial protein concentration in these supernatants 
was determined by the BCA Protein Assay (Pierce). For the experiments, these 
biofilm supernatant preparations were diluted into the final cell culture medium and 
maintained in the cell culture for up to 6 h [29]. Their concentration is expressed as 
total protein (µg/ml) present in the cell cultures. 
 
2.2 Cell cultures 
Primary human GF cell lines were established as previously described [31]. Briefly, 
gingival tissue biopsies used were obtained from healthy young individuals, who had 
their first premolar removed during the course of orthodontic treatment. Ethical 
approval was granted by the Human Studies Ethical Committee of Umeå University, 
Sweden, and informed consent was given by the subject. The cells were passaged and 
cultured in Minimum Essential Medium Alpha (Gibco), supplemented with 5 % heat-
inactivated foetal bovine serum (Sigma), 50 U/ml penicillin, and 50 µg/ml 
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streptomycin (Sigma). For the experiments, GF cells at passage 3 were seeded at 
concentration 10 x 103 cells/cm2 in antibiotics-free and 5% FBS culture medium, and 
were allowed to attach overnight, maintaining a sub-confluent status. Thereafter, the 
cells were cultured for 6 h in the presence or absence of ascending protein 
concentrations of biofilm supernatants. 
 
2.3 Cytotoxicity assay 
The GF cultures were exposed for 6 h to ascending protein concentrations of 
supernatants from the two biofilms and potential cytotoxicity was evaluated using the 
CytoTox96® Non-Radioactive Cytotoxicity Assay (Promega). 
 
2.4 RNA extraction and cDNA synthesis 
After completion of the experiments, the culture supernatants were removed from the 
culture and the cell monolayers were washed twice in PBS before being lysed. The 
collected cell lysate was homogenized with QIAshredder (QIAGEN), and total RNA 
was extracted by using the RNeasy Mini Kit (QIAGEN), according to the 
manufacturer’s instructions. RNA concentration was measured by a NanoDrop 
spectrophotometer. One µg of total RNA was then reverse transcribed into single-
stranded cDNA by using M-MLV Reverse Transcriptase, Oligo(dT)15 Primers, and 
PCR Nucleotide Mix according to the manufacturer’s protocol (all from Promega), at 
40°C for 60 min, and 70°C for 15 min. The resulting cDNA was stored at -20°C. 
 
2.5 Quantitative real-time Polymerase Chain Reaction (qPCR) 
For gene expression analyses, qPCR was performed in an ABI Prism 7000 Sequence 
Detection System and software (Applied Biosystems). 18S rRNA was used as 
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endogenous RNA control in the samples (house-keeping gene). For the amplification 
reactions, the TaqMan Gene Expression Master Mix and Gene Expression Assay kits 
from Applied Biosystems were used (assay IDs NLRP1: Hs00248187-m1 , NLRP2: 
Hs001546938-m1, NLRP3: Hs00918085-m1, ASC: Hs01547324-m1, Caspase-1: 
Hs00354836-m1, AIM2: Hs00915710-m1, IL-1β: Hs00174097-m1, IL-18: 
Hs01038787-m1, and 18S rRNA: Hs99999901-s1). The standard PCR conditions 
were 10 min at 95ºC, followed 40 cycles at 95ºC for 15 seconds and 60ºC for 1 min. 
The expression levels of the target transcripts in each sample were calculated by the 
comparative Ct method (2-∆Ct formula) after normalization to 18S rRNA. 
 
2.6 Statistical analysis 
A two-way analysis of variance (ANOVA) was used to analyze the statistical 
significances of the results, using Bonferroni post-hoc test for comparisons between 
individual groups. The data were considered significant at P<0.05. 
 
3. Results 
The GF cell cultures were challenged for 6 h with ascending concentrations of the 
supragingival or subgingival biofilm culture supernatants. Neither of these challenges 
increased toxicity compared to the control group (data not shown). 
The effect of the two biofilms on the gene expression of three NLRP 
inflammasomes was then investigated. NLRP1 and NLRP3 mRNA expressions were 
ubiquitously detected in the cells, whereas NLRP2 expression was not detected in any 
group under the present experimental conditions. Neither the supragingival nor the 
subgingival biofilm affected NLRP1 expression (Figure 1). NLRP3 mRNA levels 
were not affected by the supragingival biofilm, but the highest concentration of 
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subgingival biofilm supernatant caused an 80% down-regulation, compared to the 
control (Figure 2). When the expressions of ASC (Figure 3), Caspase-1 (Figure 4) and 
AIM2 (Figure 5) were investigated, a similar pattern of regulation was observed 
among them. Specifically, the supragingival biofilm challenge caused a 
concentration-dependent increase in their gene expression. Interestingly, the 
concentration kinetics of the subgingival biofilm challenge were different. At lower 
concentrations, ASC, Caspase-1 and AIM2, mRNA levels were increased , followed 
by a decline to control levels by the highest supernatant concentration used. 
As the activation of IL-1 cytokines is the down-stream target of 
inflammasomes, the gene expressions of IL-1β and IL-18, were also investigated. 
While IL-18 mRNA (Figure 7) was detected at lower levels than IL-1β (Figure 6), 
they were both regulated in a manner similar to AIM2, ASC and Caspase-1. Hence, 
the supragingival biofilm challenge caused a concentration-dependent increase, 
whereas the subgingival one had a biphasic effect, causing an increase in IL-1β and 
IL-18 gene expression at lower concentrations, but a decline to control levels at 
highest concentrations. 
 
4. Discussion 
This study identified that supragingival and subgingival biofilms exert differential 
effects on the gene expression of inflammasome complexes, indicating that these are 
recognised as PAMPs by the GF. The NLRP1 and NLRP2 inflammasomes do not 
appear to be of relevance to this experimental system, as the gene expression of the 
former is not affected by either biofilm challenge, whereas the latter is not expressed 
at all in GF. However, NLRP3 is responsive to oral biofilm challenge, as the gene 
expression of all of the components of this inflammasome, including ASC and 
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Caspase-1, are regulated. A differential response is observed between the 
supragingival and subgingival biofilm variants, denoting their different pathogenic 
potential for periodontal diseases. This is particularly highlighted by the drastically 
decreased NLRP3 gene expression by high concentrations of supragingival biofilm 
supernatants, also evident in ASC and Caspase-1 expressions. Hence, NLRP3 gene 
expression may have a central role within its own inflammasome complex, and a 
down-regulation could be detrimental for the expression of its other components (i.e. 
ASC and Caspase-1) in GF. Nevertheless, it is not yet clear if the observed regulations 
of inflammasome gene expression components reflect changes in the respective 
protein expressions and bioactivity. 
Although inflammasomes are responsible for controlling IL-1 cytokine 
activation rather than gene expression, IL-1β and IL-18 followed a similar pattern to 
inflammasome expression, in the present experimental system in GF. These results 
denote that oral biofilms could concomitantly regulate the expression of 
inflammasomes and their associated cytokine targets. Earlier work using semi-
quantitative qPCR has indicated that GF do not express IL-18, but express low levels 
of IL-1β mRNA [32]. The present study employing the more sensitive qPCR shows 
that IL-18 mRNA can also be detected in GF, albeit at lower levels than IL-1β. Of 
special note, the low levels of IL-1β protein production by GF [32, 33], along with the 
high cytokine-degradation effects of these in vitro biofilms [29], impose limitations in 
the study of IL-1β protein secretion in the present experimental system.  
Less information is available on the recently discovered AIM2 inflammasome, 
which is so far known as a cytosolic double-stranded DNA sensor [22, 23] and a first 
non-NLR member forming an inflammasome scaffold [11]. The fact that AIM2 gene 
expression is regulated in the present model denotes that the cells may respond to the 
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bacterial DNA present in the biofilm culture supernatant, and that active bacterial 
invasion is not a pre-requisite for this process. Despite the recognition of different 
pathogen-associated molecular patterns, the NLRP3 and AIM2 inflammasomes share 
a common feature: apart from their homonymous scaffolds they both consist of 
Caspase-1 and the ASC adaptor [11]. 
The down-regulation of NLRP3 and AIM2 inflammasomes gene expressions 
and the concomitant decrease in IL-1β and IL-18 gene expressions by the subgingival 
biofilm challenge may be an important mechanism in the pathogenesis of periodontal 
disease. Indeed, inflammasome-mediated inhibition of IL-1 cytokine processing is 
considered a strategy by bacterial and viral pathogens to manipulate the local immune 
and inflammatory responses [34], in order to survive and prevail in the periodontal 
tissue environment [35]. In fact, the molecular cross-talk of P. gingivalis with the host 
enables it to evade the normal immune responses [36], potentially benefiting other co-
habiting organisms [37]. P. gingivalis up-regulates NLRP3 [10, 38] but down-
regulates ASC expression [10, 39] in monocytic cells, whereas it down-regulates 
NLRP3, but not ASC in gingival epithelial cells. [40]. Co-infection of host cells with 
P. gingivalis and other putative periodontal pathogens, decreases the IL-1-inducing 
capacity of the latter [41, 42], denoting an antagonistic capacity. This may well be the 
case in the present experimental system utilizing subgingival biofilms, where P. 
gingivalis is present. 
The present study demonstrates that the NLRP3 and AIM2 inflammasomes are 
responsive to oral biofilm infection in GF. Supragingival and subgingival biofilms 
cause differential effects in the gene expression of these inflammasome components 
and their down-stream IL-1 targets. While typically an increase in inflammasome 
expression is commensurate with inflammatory events in periodontal disease, a 
  
12 
12 
biphasic decrease could dampen the host immune responses, in favour of pathogen 
survival. This is in line with a potential tissue-gradient effect of periodontal pathogens 
on host cells [43]. Close to the biofilm-tissue interface where the innate immune 
mechanisms are affluent, the high concentration of bacterial virulence factors on site 
may down-play these critical host defence barriers. Deeper into the periodontal 
tissues, the lower bacterial component concentration could have a stimulatory effect 
on the inflammatory responses. 
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Figure Legends 
Figure 1 
Regulation of NLRP1 gene expression in GF in response to oral biofilm challenge. 
GF cell cultures were challenged with ascending concentrations of supragingival or 
subgingival biofilm supernatants for 6 h. The gene expression levels of NLRP1 were 
measured by qPCR analysis, normalized against the expression levels of 18S rRNA 
(housekeeping gene). The results are expressed as the 2-∆CT formula. Bars represent 
mean values ± SEM from three independent experiments. The asterisk represents 
statistically significant difference between the biofilm-challenged and control groups. 
 
Figure 2 
Regulation of NLRP3 gene expression in GF in response to oral biofilm challenge. 
GF cell cultures were challenged with ascending concentrations of supragingival or 
subgingival biofilm supernatants for 6 h. The gene expression levels of NLRP3 were 
measured by qPCR analysis, normalized against the expression levels of 18S rRNA 
(housekeeping gene). The results are expressed as the 2-∆CT formula. Bars represent 
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mean values ± SEM from three independent experiments. The asterisk represents 
statistically significant difference between the biofilm-challenged and control groups. 
 
Figure 3 
Regulation of ASC gene expression in GF in response to oral biofilm challenge. GF 
cell cultures were challenged with ascending concentrations of supragingival or 
subgingival biofilm supernatants for 6 h. The gene expression levels of ASC were 
measured by qPCR analysis, normalized against the expression levels of 18S rRNA 
(housekeeping gene). The results are expressed as the 2-∆CT formula. Bars represent 
mean values ± SEM from three independent experiments. The asterisk represents 
statistically significant difference between the biofilm-challenged and control groups. 
 
Figure 4 
Regulation of Caspase-1 gene expression in GF in response to oral biofilm 
challenge. GF cell cultures were challenged with ascending concentrations of 
supragingival or subgingival biofilm supernatants for 6 h. The gene expression levels 
of Caspase-1 were measured by qPCR analysis, normalized against the expression 
levels of 18S rRNA (housekeeping gene). The results are expressed as the 2-∆CT 
formula. Bars represent mean values ± SEM from three independent experiments. The 
asterisk represents statistically significant difference between the biofilm-challenged 
and control groups. 
 
Figure 5 
Regulation of AIM2 gene expression in GF in response to oral biofilm challenge. 
GF cell cultures were challenged with ascending concentrations of supragingival or 
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subgingival biofilm supernatants for 6 h. The gene expression levels of AIM2 were 
measured by qPCR analysis, normalized against the expression levels of 18S rRNA 
(housekeeping gene). The results are expressed as the 2-∆CT formula. Bars represent 
mean values ± SEM from three independent experiments. The asterisk represents 
statistically significant difference between the biofilm-challenged and control groups. 
 
Figure 6 
Regulation of IL-1β gene expression in GF in response to oral biofilm challenge. 
GF cell cultures were challenged with ascending concentrations of supragingival or 
subgingival biofilm supernatants for 6 h. The gene expression levels of IL-1β were 
measured by qPCR analysis, normalized against the expression levels of 18S rRNA 
(housekeeping gene). The results are expressed as the 2-∆CT formula. Bars represent 
mean values ± SEM from three independent experiments. The asterisk represents 
statistically significant difference between the biofilm-challenged and control groups. 
 
Figure 7 
Regulation of IL-18 gene expression in GF in response to oral biofilm challenge. 
GF cell cultures were challenged with ascending concentrations of supragingival or 
subgingival biofilm supernatants for 6 h. The gene expression levels of IL-18 were 
measured by qPCR analysis, normalized against the expression levels of 18S rRNA 
(housekeeping gene). The results are expressed as the 2-∆CT formula. Bars represent 
mean values ± SEM from three independent experiments. The asterisk represents 
statistically significant difference between the biofilm-challenged and control groups. 
 
 
  
19 
19 
 
 
 
  
20 
20 
 
 
  
21 
21 
 
 
  
22 
22 
 
 
